Restricted
Neonatal:
Data from adult studies unless otherwise noted
Oral bioavailability: 78 to 89% (decreased in neonates)
Plasma Protein Binding: 3 to 4%
Elimination: Eliminated primarily as unchanged drug by the kidneys by glomerular filtration. Increase dosing interval in neonates with impaired renal function and monitor trough serum flucytosine levels closely